Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0151 | 0.1606 | 0.4067 |
Leishmania major | mitochondrial DNA polymerase beta | 0.0319 | 0.395 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0056 | 0.0283 | 0.0608 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0283 | 0.2638 |
Brugia malayi | hypothetical protein | 0.0356 | 0.446 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0051 | 0.0379 |
Brugia malayi | AMP-binding enzyme family protein | 0.0053 | 0.0237 | 0.0506 |
Brugia malayi | AMP-binding enzyme family protein | 0.0053 | 0.0237 | 0.0506 |
Entamoeba histolytica | hypothetical protein | 0.0356 | 0.446 | 1 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0053 | 0.0237 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0168 | 0.1844 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0053 | 0.0237 | 0.1186 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0053 | 0.0237 | 0.0601 |
Loa Loa (eye worm) | hypothetical protein | 0.011 | 0.1037 | 1 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0039 | 0.0051 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0056 | 0.0283 | 0.0608 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.0237 | 0.2196 |
Onchocerca volvulus | 0.011 | 0.1037 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.0035 | 0.0225 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0053 | 0.0237 | 0.0532 |
Entamoeba histolytica | hypothetical protein | 0.0356 | 0.446 | 1 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0039 | 0.0051 | 0.0165 |
Mycobacterium ulcerans | hypothetical protein | 0.0168 | 0.1844 | 1 |
Trypanosoma cruzi | DNA polymerase beta thumb, putative | 0.0045 | 0.0126 | 0.0319 |
Schistosoma mansoni | hypothetical protein | 0.0356 | 0.446 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0051 | 0.0379 |
Echinococcus multilocularis | tumor protein p63 | 0.0753 | 1 | 1 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.011 | 0.1037 | 0.2305 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0053 | 0.0237 | 0.1039 |
Trypanosoma cruzi | DNA polymerase beta thumb, putative | 0.0045 | 0.0126 | 0.0319 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0319 | 0.395 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0037 | 0.0012 | 1 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0053 | 0.0237 | 0.5 |
Trypanosoma brucei | DNA polymerase beta thumb, putative | 0.0045 | 0.0126 | 0.0319 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0038 | 0.0035 | 0.0052 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0319 | 0.395 | 1 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0053 | 0.0237 | 0.1039 |
Brugia malayi | AMP-binding enzyme family protein | 0.0053 | 0.0237 | 0.0506 |
Toxoplasma gondii | hypothetical protein | 0.0051 | 0.0218 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0051 | 0.0379 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0053 | 0.0237 | 0.1039 |
Mycobacterium ulcerans | hypothetical protein | 0.0053 | 0.0237 | 0.1039 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0319 | 0.395 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0356 | 0.446 | 1 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0053 | 0.0237 | 0.0532 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0053 | 0.0237 | 0.1039 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.0237 | 0.2196 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0051 | 0.0379 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0356 | 0.446 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.0237 | 0.2196 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0053 | 0.0237 | 0.1039 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0053 | 0.0237 | 0.0601 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0151 | 0.1606 | 0.4067 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0045 | 0.0126 | 0.0319 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0053 | 0.0237 | 0.1186 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0056 | 0.0283 | 0.2638 |
Trichomonas vaginalis | rotamase, putative | 0.0037 | 0.0012 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0053 | 0.0237 | 0.1039 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0356 | 0.446 | 0.4454 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0053 | 0.0237 | 0.1039 |
Leishmania major | mitochondrial DNA polymerase beta-PAK, putative | 0.0151 | 0.1606 | 0.4067 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0356 | 0.446 | 0.4454 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0039 | 0.0051 | 0.5 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0053 | 0.0237 | 0.0532 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0039 | 0.0051 | 0.5 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0053 | 0.0237 | 0.0601 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0055 | 0.0263 | 0.0666 |
Entamoeba histolytica | hypothetical protein | 0.0356 | 0.446 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0051 | 0.0379 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.0035 | 0.0052 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.